Biotypes and antimicrobial susceptibilities of Brucella isolates

被引：66

作者：

Bodur, H

Balaban, N

Aksaray, S

Yetener, V

Akinci, E

Çolpan, A

Erbay, A

机构：

[1] Ankara Numune Training & Res Hosp, Infect Dis & Clin Microbiol Clin, Ankara, Turkey

[2] Ankara Numune Training & Res Hosp, Microbiol Sect, Ankara, Turkey

来源：

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2003年 / 35卷 / 05期

关键词：

D O I：

10.1080/00365540310008348

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

41 Brucella strains isolated from blood and cerebrospinal fluid cultures were identified to species level and biotypes detected. An of the isolates were Brucella melitensis: 2 strains of B. melitensis biotype-1 and 39 strains of B. melitensis biotype-3. In vitro activities of these strains were detected by the E test method. According to the 90% minimal inhibitory concentration (MIC90) values, the most active agent was doxycycline (MIC90 0.064 mug/ml), followed by ciprofloxacin (MIC90 0.25 mug/ml), trimethoprim-sulfamethoxazole and ceftriaxone (MIC90 0.38 mug/ml). Rifampin exhibited the highest MIC90 value (0.75 mug/ml).

引用

收藏

页码：337 / 338

页数：2

相关论文

共 11 条

[1] In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs [J].

Akova, M ;

Gür, D ;

Livermore, DM ;

Kocagöz, T ;

Akalin, HE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1298-1300

[2]

ALTON G. G., 1988, TECHNIQUES BRUCELLOS

[3] LACK OF EFFECTIVE BACTERICIDAL ACTIVITY OF NEW QUINOLONES AGAINST BRUCELLA SPP [J].

GARCIARODRIGUEZ, JA ;

SANCHEZ, JEG ;

TRUJILLANO, I .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :756-759

[4] Comparison of E test to microdilution for determining in vitro activities of antibiotics against Brucella melitensis [J].

Gür, D ;

Kocagöz, S ;

Akova, M ;

Unal, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2337-2337

[5] Increasing resistance of brucellae to co-trimoxazole [J].

Kinsara, A ;

Al-Mowallad, A ;

Osoba, AO .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1531-1531

[6] In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey [J].

Kocagöz, S ;

Akova, M ;

Altun, B ;

Gür, D ;

Hasçelik, G .

CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (04) :240-242

[7]

MOREY NP, 1995, MANUAL CLIN MICROBIO, P549

[8]

QADRI SMH, 1989, DRUG EXP CLIN RES, V15, P483

[9] INVITRO SUSCEPTIBILITY OF BRUCELLA-MELITENSIS TO ANTIBIOTICS [J].

RUBINSTEIN, E ;

LANG, R ;

SHASHA, B ;

HAGAR, B ;

DIAMANSTEIN, L ;

JOSEPH, G ;

ANDERSON, M ;

HARRISON, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1925-1927

[10] In vitro activities of six new fluoroquinolones against Brucella melitensis [J].

Trujillano-Martín, I ;

García-Sánchez, E ;

Martínez, IM ;

Fresnadillo, MJ ;

García-Sánchez, JE ;

García-Rodríguez, JA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) :194-195